Tingley Whittemore 4
4 · Tenaya Therapeutics, Inc. · Filed Feb 5, 2026
Research Summary
AI-generated summary of this filing
Tenaya (TNYA) CMO Tingley Whittemore Receives RSU and Option Awards
What Happened Tingley Whittemore, Chief Medical Officer of Tenaya Therapeutics (TNYA), was granted two equity awards on February 3, 2026: 48,750 restricted stock units (RSUs) and a derivative award covering 318,500 shares (an option). Both grants were reported with an acquisition price of $0.00. These are compensatory grants (not open‑market purchases or sales) that vest over time; they represent a potential 367,250 shares if fully vested/exercised.
Key Details
- Transaction date: February 3, 2026; Form 4 filed February 5, 2026 (appears timely).
- Grant amounts: 48,750 RSUs (F1) and 318,500‑share option award (derivative).
- Reported acquisition price: $0.00 for both grants.
- Vesting - RSUs (F2): 1/8 of the total vests on August 15, 2026, then 1/8 every six months thereafter until fully vested.
- Vesting - Option (F4): vests monthly — 1/48th after one month, then 1/48th each monthly anniversary until fully vested.
- Shares reflected in ownership (F3): filing notes 134,588 shares that will be issued upon RSU vesting are included in the reported beneficial ownership figure.
- Nature of transaction: Award/grant (code A) — not an immediate purchase or sale; no cash proceeds or disposition reported.
Context
- RSUs convert to actual shares when vested; options give the right to acquire shares per the plan and vesting schedule. These awards are typical executive compensation and do not indicate an immediate market trade.
Insider Transaction Report
Form 4
Tingley Whittemore
Chief Medical Officer
Transactions
- Award
Common Stock
[F1][F2][F3]2026-02-03+48,750→ 223,778 total - Award
Stock Option (Right to buy)
[F4]2026-02-03+318,500→ 318,500 totalExercise: $0.92From: 2026-03-03Exp: 2036-02-02→ Common Stock (318,500 underlying)
Footnotes (4)
- [F1]Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock.
- [F2]The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on August 15, 2026, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested.
- [F3]Includes 134,588 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- [F4]Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested.
Signature
/s/ Jennifer Drimmer Rokovich, Attorney in Fact|2026-02-05